Myriad Genetics - EndoPredict Business - Ownership and Business Overview

Life ScienceCompany

Myriad Genetics - EndoPredict Business Ownership

Who owns Myriad Genetics - EndoPredict Business?

Myriad Genetics - EndoPredict Business is owned by Myriad Genetics. It was acquired on May 7, 2024.

Myriad Genetics - EndoPredict Business Business Overview

Where is Myriad Genetics - EndoPredict Business headquartered?

Myriad Genetics - EndoPredict Business is headquartered in Salt Lake City, Utah.

What sector is Myriad Genetics - EndoPredict Business in?

Myriad Genetics - EndoPredict Business is a life science company.

Life Science M&A Summary in 2024

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2024. The largest life science acquisition in 2024 was Catalent - which was acquired by Novo Holdings A/S for $16.5B.

Join Mergr to view all 192 acquisitions of life science companies in 2024, including 15 acquisitions by private equity firms, and 177 by strategics.

Myriad Genetics - EndoPredict Business

Myriad Genetics - EndoPredict Business

Salt Lake City, Utah 84108
United States,

Myriad Genetics' EndoPredict Business offers a comprehensive suite of precision medicine tools for breast, prostate, ovarian, pancreatic, endometrial, and colon cancer. Myriad Genetics' EndoPredict Business is based in Salt Lake City, Utah.


 Subscribe to unlock this and 207,814
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 200K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.